In this report, the expanded high-cost claim conditions analysis that was published as an early release in May is combined with our new top 20 injectable drugs list and the latest data on million-dollar+ claims. A healthcare update is also included, covering what we have seen to date on COVID-19 claims, the latest information on Zolgensma and a new emerging gene therapy, and several legislative updates. Click the download button below to get your free copy of the “High-cost claims and injectable drug trends analysis".
2020 Stop-Loss Research Report
November 2020
Group insurance policies are underwritten by Sun Life Assurance Company of Canada (Wellesley Hills, MA) in all states, except New York. In New York group insurance policies are issued by Sun Life and Health Insurance Company (U.S.) (Lansing, MI). Product offerings may not be available in all states and may vary depending on state laws and regulations.
SLPC 30728 03/21 (exp. 03/23)